283 related articles for article (PubMed ID: 19112153)
1. Metabotropic glutamate 1 receptor: current concepts and perspectives.
Ferraguti F; Crepaldi L; Nicoletti F
Pharmacol Rev; 2008 Dec; 60(4):536-81. PubMed ID: 19112153
[TBL] [Abstract][Full Text] [Related]
2. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].
Luján-Miras R
Rev Neurol; 2005 Jan 1-15; 40(1):43-53. PubMed ID: 15696426
[TBL] [Abstract][Full Text] [Related]
3. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.
Spooren W; Ballard T; Gasparini F; Amalric M; Mutel V; Schreiber R
Behav Pharmacol; 2003 Jul; 14(4):257-77. PubMed ID: 12838033
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.
Lesage A; Steckler T
Eur J Pharmacol; 2010 Aug; 639(1-3):2-16. PubMed ID: 20371230
[TBL] [Abstract][Full Text] [Related]
5. Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia.
Landucci E; Boscia F; Gerace E; Scartabelli T; Cozzi A; Moroni F; Mannaioni G; Pellegrini-Giampietro DE
Int Rev Neurobiol; 2009; 85():337-50. PubMed ID: 19607979
[TBL] [Abstract][Full Text] [Related]
6. Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.
Ritzén A; Mathiesen JM; Thomsen C
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):202-13. PubMed ID: 16176554
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.
Schoepp DD
J Pharmacol Exp Ther; 2001 Oct; 299(1):12-20. PubMed ID: 11561058
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
[TBL] [Abstract][Full Text] [Related]
9. The distinct role of mGlu1 receptors in post-ischemic neuronal death.
Pellegrini-Giampietro DE
Trends Pharmacol Sci; 2003 Sep; 24(9):461-70. PubMed ID: 12967771
[TBL] [Abstract][Full Text] [Related]
10. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues.
Julio-Pieper M; Flor PJ; Dinan TG; Cryan JF
Pharmacol Rev; 2011 Mar; 63(1):35-58. PubMed ID: 21228260
[TBL] [Abstract][Full Text] [Related]
11. Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis.
Dhami GK; Ferguson SS
Pharmacol Ther; 2006 Jul; 111(1):260-71. PubMed ID: 16574233
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of group I mGlu receptors in striatal function.
Bonsi P; Platania P; Martella G; Madeo G; Vita D; Tassone A; Bernardi G; Pisani A
Neuropharmacology; 2008 Sep; 55(4):392-5. PubMed ID: 18602651
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.
Swanson CJ; Bures M; Johnson MP; Linden AM; Monn JA; Schoepp DD
Nat Rev Drug Discov; 2005 Feb; 4(2):131-44. PubMed ID: 15665858
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate receptors.
Ferraguti F; Shigemoto R
Cell Tissue Res; 2006 Nov; 326(2):483-504. PubMed ID: 16847639
[TBL] [Abstract][Full Text] [Related]
15. Antagonist-induced supersensitivity of mGlu1 receptor signalling in cerebellar granule cells.
Lavreysen H; Willemoens T; Leysen JE; Lesage AS
Eur J Neurosci; 2005 Mar; 21(6):1610-6. PubMed ID: 15845088
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
17. Glutamate and GABA receptor signalling in the developing brain.
Luján R; Shigemoto R; López-Bendito G
Neuroscience; 2005; 130(3):567-80. PubMed ID: 15590141
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate 2/3 receptors as drug targets.
Marek GJ
Curr Opin Pharmacol; 2004 Feb; 4(1):18-22. PubMed ID: 15018834
[TBL] [Abstract][Full Text] [Related]
19. Regulatory role of C-terminus in the G-protein coupling of the metabotropic glutamate receptor 1.
Tateyama M; Kubo Y
J Neurochem; 2008 Nov; 107(4):1036-46. PubMed ID: 18786167
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic gestational treatment with the adenosine A1 receptor agonist R-phenylisopropyladenosine on metabotropic glutamate receptors/phospholipase C pathway in maternal and fetal brain.
León DA; Albasanz JL; Castillo CA; Iglesias I; Martín M
J Neurosci Res; 2008 Nov; 86(15):3295-305. PubMed ID: 18615645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
